Patents by Inventor Veronique Mary

Veronique Mary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • H3 receptor antagonist for use in the treatment of alzheimer's disease
    Patent number: 9789102
    Abstract: This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of Alzheimer's disease, other tauopathies and related neurodegenerative diseases.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: October 17, 2017
    Assignee: SANOFI
    Inventors: Pascal Barneoud, Veronique Blanchard-Bregeon, Veronique Mary, Jean Menager, Philippe Delay-Goyet, Mathilde Lopez-Grancha, Thomas Rooney, Nathalie Schussler
  • H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20160101099
    Abstract: This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of Alzheimer's disease, other tauopathies and related neurodegenerative diseases.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 14, 2016
    Inventors: Pascal BARNEOUD, Veronique BLANCHARD-BREGEON, Veronique MARY, Jean MENAGER, Philippe DELAY-GOYET, Mathilde LOPEZ-GRANCHA, Thomas ROONEY, Nathalie SCHUSSLER
  • AN H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20150031893
    Abstract: This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of Alzheimer's disease, other tauopathies and related neurodegenerative diseases.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 29, 2015
    Inventors: Pascal BARNEOUD, Veronique BLANCHARD-BREGEON, Veronique MARY, Jean MENAGER, Philippe DELAY-GOYET, Mathilde LOPEZ GRANCHA, Thomas ROONEY, Nathalie SCHUSSLER
  • Novel therapeutic application of enoxaparin
    Publication number: 20040214796
    Abstract: The present invention relates to the use of enoxaparin for reducing cerebral lesion size in the treatment of cerebral ischemia.
    Type: Application
    Filed: May 19, 2004
    Publication date: October 28, 2004
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Veronique Mary, Jean-Marie Stutzmann, Andre Uzan, Florence Wahl
  • Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas
    Patent number: 6579858
    Abstract: Cerebral edema is prevented and treated by administering an effective amount of a low molecular weight heparin.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: June 17, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Véronique Mary, Jérémy Pratt, Jean-Marie Stutzman, André Uzan, Florence Wahl
  • Novel therapeutic application of enoxaparin
    Publication number: 20010041686
    Abstract: The present invention relates to the use of enoxaparin for the treatment of cerebral ischemia.
    Type: Application
    Filed: January 2, 2001
    Publication date: November 15, 2001
    Inventors: Veronique Mary, Jean-Marie Stutzmann, Andre Uzan, Florence Wahl